The reported statements, read against the company's own industry.
Financials view
Market Capitalization
6.35BUSD
vs all stocks (USD)
Updated Jul 18, 2026
Trailing P/E
41.47x
Updated Jul 18, 2026
Revenue (TTM)
995.33MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Profit Margin
15.27%
Updated Jul 18, 2026
Beta
0.7920x
vs all stocks
Updated Jul 18, 2026
52-Week Change
-28.74%
vs all stocks
Updated Jul 18, 2026
Market Capitalization
6.35BUSD
vs all stocks (USD)
Updated Jul 18, 2026
Enterprise Value
6.09BUSD
vs all stocks (USD)
Updated Jul 18, 2026
Trailing P/E
41.47x
Updated Jul 18, 2026
Forward P/E
21.33x
Updated Jul 18, 2026
PEG Ratio
1.08x
Updated Jul 18, 2026
Price to Sales (TTM)
6.23x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 6.38×.Updated Jul 18, 2026
Price to Book (MRQ)
13.19x
Updated Jul 18, 2026
Enterprise to Revenue
6.12x
Updated Jul 18, 2026
Enterprise to EBITDA
33.25x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 31.45×.Updated Jul 18, 2026
Gross Margin
63.78%
Updated Jul 18, 2026
Profit Margin
15.27%
Updated Jul 18, 2026
Operating Margin
19.35%
Updated Jul 18, 2026
Return on Assets (TTM)
18.54%
Updated Jul 18, 2026
Return on Equity (TTM)
32.60%
Updated Jul 18, 2026
Revenue (TTM)
995.33MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Revenue per Share (TTM)
27.75USDUpdated Jul 18, 2026
Quarterly Revenue Growth
20.40%
Updated Jul 18, 2026
Gross Profit (TTM)
634.52MUSD
vs all stocks (USD)
Updated Jul 18, 2026
EBITDA (TTM)
193.58MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Net Income (TTM)
151.96MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Quarterly Earnings Growth (YoY)
35.20%
Updated Jul 18, 2026
Operating Cash Flow (TTM)
237.94MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Levered Free Cash Flow (TTM)
177.61MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Jul 18, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Jul 18, 2026
Payout Ratio
0.00%
Updated Jul 18, 2026
Revenue
950.82MUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
345.34MUSDFY2025 · Dec 31, 2025
Gross Profit
605.48MUSDFY2025 · Dec 31, 2025
Operating Income
152.92MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
161.11MUSDFY2025 · Dec 31, 2025
Income Tax Expense
20.19MUSDFY2025 · Dec 31, 2025
Net Income
140.92MUSDFY2025 · Dec 31, 2025
EBIT
152.92MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
177.79MUSDFY2025 · Dec 31, 2025
Research & Development
190.42MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
239.49MUSDFY2025 · Dec 31, 2025
Non-operating Interest Income
8.16MUSDFY2025 · Dec 31, 2025
EPS (Basic)
3.91USDFY2025 · Dec 31, 2025
EPS (Diluted)
3.88USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
36.01MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
36.01MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
140.92MUSDFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00USDFY2025 · Dec 31, 2025
Operating Cash Flow
248.70MUSDFY2025 · Dec 31, 2025
Free Cash Flow
245.54MUSDDerived from operating cash flow minus capital expenditure. This filing charges 24.87M of depreciation against 3.16M of capital expenditure, and its own free-cash-flow line reads 235.51M.FY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
107.22MUSDFY2025 · Dec 31, 2025
Income Tax Paid
28.84MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
140.92MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
24.87MUSDFY2025 · Dec 31, 2025
Deferred Taxes (CF)
18.14MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
70.79MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
9.00MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-12.53MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
1.77MUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-4.26MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-3.15MUSDFY2025 · Dec 31, 2025
Net Acquisitions
-906.00KUSDFY2025 · Dec 31, 2025
Purchase of Investments
-303.89MUSDFY2025 · Dec 31, 2025
Sale of Investments
321.63MUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
13.68MUSDFY2025 · Dec 31, 2025
Common Stock Repurchase
-145.72MUSDFY2025 · Dec 31, 2025
Other Financing Charges
-43.25MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
-188.02MUSDFY2025 · Dec 31, 2025
Shares Outstanding
35.36MSharesUpdated Jul 18, 2026
Float Shares
22.92MSharesUpdated Jul 18, 2026
Shares Short
2.62MSharesUpdated Jul 18, 2026
Short Ratio
6.57days
vs all stocks
Updated Jul 18, 2026
Short % of Shares Outstanding
10.91%
vs all stocks
Provider-reported. Shares Short ÷ Shares Outstanding on this page gives 7.4%.Updated Jul 18, 2026
% Held by Insiders
4.70%
vs all stocks
Updated Jul 18, 2026
% Held by Institutions
92.26%
vs all stocks
Updated Jul 18, 2026
Total Cash (MRQ)
151.65MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Total Cash per Share (MRQ)
4.29USDUpdated Jul 18, 2026
Total Debt (MRQ)
36.98MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Total Debt to Equity (MRQ)
0.0786x
Updated Jul 18, 2026
Current Ratio (MRQ)
3.52x
Updated Jul 18, 2026
Book Value per Share (MRQ)
13.30USDUpdated Jul 18, 2026
Total Assets
688.97MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
353.31MUSDFY2025 · Dec 31, 2025
Total Liabilities
146.39MUSDFY2025 · Dec 31, 2025
Total Non-current Assets
335.65MUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
39.54MUSDFY2025 · Dec 31, 2025
Total Current Liabilities
106.85MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
106.97MUSDFY2025 · Dec 31, 2025
Other Short-term Investments
144.26MUSDFY2025 · Dec 31, 2025
Accounts Receivable
36.87MUSDFY2025 · Dec 31, 2025
Accounts Payable
4.12MUSDFY2025 · Dec 31, 2025
Short-term Debt
4.87MUSDFY2025 · Dec 31, 2025
Other Current Liabilities
10.62MUSDFY2025 · Dec 31, 2025
Long-term Debt
33.29MUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
6.25MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
4.00KUSDFY2025 · Dec 31, 2025
Retained Earnings
430.97MUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
542.58MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
172.48MUSDFY2025 · Dec 31, 2025
52-Week Low
142.56USDUpdated Jul 18, 2026
52-Week High
326.04USDUpdated Jul 18, 2026
52-Week Change
-28.74%
vs all stocks
Updated Jul 18, 2026
Beta
0.7920x
vs all stocks
Updated Jul 18, 2026
50-Day MA
163.38USDUpdated Jul 18, 2026
200-Day MA
196.26USDUpdated Jul 18, 2026
Avg 10-Day Volume
329.27KSharesUpdated Jul 18, 2026
Avg 30-Day Volume
372.51KSharesUpdated Jul 18, 2026
Diluted EPS (TTM)
4.23USDUpdated Jul 18, 2026
Other Income / Expense
38.00KUSDFY2025 · Dec 31, 2025
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total Liabilities
Cash covers most of its debt, with earnings high against its liabilities.
Reads
How does this company use capital?
Operating Income Growing With Multi-Year Revenue Growth
Revenue up in each of five years, with operating income up in each of four.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Scale
Market cap is $6.35B, above the global median of $1.15BNotable
Market cap (USD): 6,354,989,136Global Median: 1,146,734,693.424
Revenue is $995.33M, above the global median of $520.53MNotable
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesOperating Income Growing With Multi-Year Revenue Growth
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesOperating Income Growing With Multi-Year Revenue Growth
MRQ Cash Elevated Relative To Total Debt With EBITDA And FCF Elevated Relative To Total LiabilitiesOperating Income Growing With Multi-Year Revenue Growth